Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group

Article

Abstract: Purpose: To assess whether the addition of epirubicin (EPI) therapy to prolonged treatment with tamo

Palabras claves:

Autores:

Bliss J.M., Coombes G., Coombes R.C., Faustino R. Pérez-López, Fontaine C., Marty M., Morvan F., Olmos T., Vassilopoulos P., Wils J.A., Woods E.M.

Fuentes:

scopus